|
|
|
|
University of Michigan Health Rogel Cancer Center were included on the 2023 list of Highly Cited Researchers. Published by Clarivate Analytics, the annual list highlights researchers who have demonstrated significant and broad influence in their area of research and who have authored multiple papers ranked in the top 1% by citations in their field.
|
|
|
Daniel F. Hayes, M.D., received the Brinker Award for Clinical Research from Susan G. Komen, the world’s leading breast cancer organization. The award recognizes physician-scientists for their work to drive discoveries and improve breast cancer patient outcomes.
|
Three Rogel Cancer Center researchers have received new grants from the American Cancer Society for projects focused on cervical cancer screening, genetic testing and glioblastoma. The grants, which include a Research Scholar Grant to Diane Harper and two postdoctoral fellow grants, total $1.16 million.
|
With a new $3.4 million grant from the National Cancer Institute, a team of Rogel Cancer Center researchers will develop new tools to detect changes in precancerous lesions that are likely to become oral cancers. When detected early, this type of head and neck cancer can be curable.
|
Colorectal cancer screening is widely recommended for adults ages 45 to 75 with an average risk of developing the disease. However, many people don’t realize that the benefits of screening for this type of cancer aren’t always the same for older adults.
|
Experts at the University of Michigan Health Rogel Cancer Center have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow.
|
|
|
MENU